Par4 Gene Cancer: Clinical Trials & Cancer Resistance

In summary: The Par-4 gene has been shown to work in multiple ways to suppress tumors, including interfering with signaling that promotes tumor growth. In experiments with mice, injecting Par-4 adenovirus into tumors resulted in significant shrinking of the tumors, while control tumors continued to grow. This suggests that the Par-4 gene does not necessarily need to be in the nucleus to have an effect. However, further research is needed to determine if Par-4 can be forced into the nucleus through the use of a virus or other means.
  • #1
bioquest
319
0
Are there any clinical trials or anything like that involving par4 gene and humans to make people more cancer-resistant, do you think it would work to make people cancer-resistant like it does in mice?

if there was a cancer resistant person do you think their white blood cells would cure cancer in mice like white blood cells from cancer resistant mice cure cancer in mice?
 
Biology news on Phys.org
  • #2
Could somebody tell me what par4 stands for (the gene that makes things cancer-resistant) does it stand for Prostate Apoptosis Response-4 or does it stand for Protease-activated receptor-4 (PAR4)- could you let me know where you found out which one it stands for? I read that it can cure cancer/stop cancer from forming, does anyone know if it works for every type? I read that it worked for even aggressive types
 
  • #3
So, par4 doesn't kill all typees of cancer cells, but maybe because it interfers with signaling that promotes tumor growth it could help stop all types of cancers?

http://www.nyas.org/annals/annalsExtra.asp?annalID=34the new york academy of science says

"Par-4 does not kill all types of cancer cells. In cancer cells that resist Par-4, such as hormone-dependent tumors, there is sufficient PKA to allow phosphorylation to take place, but Par-4 is still kept out of the nucleus, meaning the cell survives."

Tumors in mice regressed quickly after treatment
"Par-4 also works in other ways. Previous work showed that Par-4 can suppress tumors by interfering with signaling that promotes tumor growth. In one experiment, when Par-4 was purposely overexpressed in cancer cells, they were prevented from forming colonies in a soft agar medium. In another, tumors were started in mice and allowed to grow. Then the tumors were injected either with Par-4 adenovirus (a viral vector delivery system), or with a control viral vector. After about three weeks, all twenty of the tumors injected with Par-4 shrank markedly, while the other tumors continued to grow apace."

"The researchers named the region of Par-4 responsible for singling out cancer cells the Selective Apoptosis of Cancer (SAC) domain. The protein is being developed as a potential therapeutic agent against an array of cancers, not just tumors of the prostate. Says Rangnekar, "The best part is that despite the apoptotic effect in cancer cells, neither the SAC domain nor Par-4 induces apoptosis in normal cells—implying that treatment should be non-toxic and safe." Also, the fact that Par-4 targets cancer in different ways provides multiple opportunities for drug development."
 
Last edited:
  • #4
sorry I can't edit posts

I mean does par-4 need to be in the nucleus of the cell to be overexpressed
because it says this
"Par-4 does not kill all types of cancer cells. In cancer cells that resist Par-4, such as hormone-dependent tumors, there is sufficient PKA to allow phosphorylation to take place, but Par-4 is still kept out of the nucleus, meaning the cell survives."
and then it says this

"Par-4 also works in other ways. Previous work showed that Par-4 can suppress tumors by interfering with signaling that promotes tumor growth. In one experiment, when Par-4 was purposely overexpressed in cancer cells, they were prevented from forming colonies in a soft agar medium. In another, tumors were started in mice and allowed to grow. Then the tumors were injected either with Par-4 adenovirus (a viral vector delivery system), or with a control viral vector. After about three weeks, all twenty of the tumors injected with Par-4 shrank markedly, while the other tumors continued to grow apace."

when the tumors were injected with the par-4 adenovirus/a control viral vector- did the par4 gene not need to get into the nucleus to work? Maybe par4 doesn't need to get into the nucleus if it interferes with signaling that inhibits tumor growth? Sorry for writing so much, thanks
 
  • #5
My only question is:

could you force par 4 into the nucleus, with a virus or something, if it's kept out of the nucleus?
"In cancer cells that resist Par-4, such as hormone-dependent tumors, there is sufficient PKA to allow phosphorylation to take place, but Par-4 is still kept out of the nucleus, meaning the cell survives."
 

Related to Par4 Gene Cancer: Clinical Trials & Cancer Resistance

What is the PAR4 gene and how does it relate to cancer?

The PAR4 gene, also known as the protease-activated receptor 4 gene, is a protein-coding gene that is involved in cell signaling pathways. It has been linked to the development, progression, and resistance of certain types of cancer.

What are clinical trials and how are they used in studying the PAR4 gene in relation to cancer?

Clinical trials are research studies that involve human participants and are used to evaluate the safety and effectiveness of new medical treatments, interventions, or procedures. In the context of the PAR4 gene and cancer, clinical trials are used to test potential therapies that target the PAR4 gene in cancer cells, with the goal of improving outcomes for cancer patients.

How does the PAR4 gene impact cancer resistance?

The PAR4 gene has been found to play a role in cancer resistance, which is when cancer cells are able to survive and continue to grow despite treatment. This can occur due to mutations in the PAR4 gene or changes in its expression, which can affect the sensitivity of cancer cells to certain treatments.

What are the current challenges in developing treatments targeting the PAR4 gene for cancer?

One of the main challenges in developing treatments targeting the PAR4 gene for cancer is the complexity of the gene and its role in various types of cancer. Additionally, identifying effective therapies that specifically target the PAR4 gene without causing harm to normal cells is a major hurdle in the development of these treatments.

What are the potential implications of PAR4 gene research for cancer treatment?

Research on the PAR4 gene could potentially lead to the development of more targeted and effective treatments for certain types of cancer. By understanding the role of the PAR4 gene in cancer resistance, researchers may be able to develop therapies that can overcome this resistance and improve outcomes for cancer patients.

Similar threads

  • Biology and Medical
Replies
2
Views
1K
  • Biology and Medical
Replies
4
Views
3K
Replies
1
Views
1K
  • Biology and Medical
Replies
5
Views
2K
  • Biology and Medical
Replies
11
Views
5K
Replies
1
Views
1K
  • Biology and Medical
Replies
7
Views
2K
  • Biology and Medical
Replies
13
Views
4K
Replies
4
Views
997
Back
Top